BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2011028)

  • 21. Do cancer patients with chemotherapy-induced leukopenia benefit from an antiseptic chlorhexidine-based oral rinse? A double-blind, block-randomized, controlled study.
    Pitten FA; Kiefer T; Buth C; Doelken G; Kramer A
    J Hosp Infect; 2003 Apr; 53(4):283-91. PubMed ID: 12660125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of chlorhexidine and benzydamine mouthwashes on mucositis induced by therapeutic irradiation.
    Samaranayake LP; Robertson AG; MacFarlane TW; Hunter IP; MacFarlane G; Soutar DS; Ferguson MM
    Clin Radiol; 1988 May; 39(3):291-4. PubMed ID: 3293887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oropharyngeal mucositis complicating bone marrow transplantation: prognostic factors and the effect of chlorhexidine mouth rinse.
    Weisdorf DJ; Bostrom B; Raether D; Mattingly M; Walker P; Pihlstrom B; Ferrieri P; Haake R; Goldman A; Woods W
    Bone Marrow Transplant; 1989 Jan; 4(1):89-95. PubMed ID: 2647192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sucralfate mouth washing in the prevention of radiation-induced mucositis: a placebo-controlled double-blind randomized study.
    Makkonen TA; Boström P; Vilja P; Joensuu H
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):177-82. PubMed ID: 8083112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pilot study of the effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients during X-radiation therapy: a preliminary report.
    Nicolatou O; Sotiropoulou-Lontou A; Skarlatos J; Kyprianou K; Kolitsi G; Dardoufas K
    Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):551-6. PubMed ID: 9806514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
    Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Oral hygiene in radiation patients. Evaluation of the effect of oral hygiene measures in the treatment of mucositis of the oral mucosa during radiation therapy].
    Spijkervet FK; Boering G; Panders AK; Vermey A; Dun JA; Menta DM; Zwart J
    Ned Tijdschr Tandheelkd; 1985 Mar; 92(3):85-8. PubMed ID: 3858698
    [No Abstract]   [Full Text] [Related]  

  • 28. Mucosal microflora in head and neck cancer patients.
    Almståhl A; Finizia C; Carlén A; Fagerberg-Mohlin B; Alstad T
    Int J Dent Hyg; 2018 Nov; 16(4):459-466. PubMed ID: 29766652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The correlation between epidermal growth factor levels in saliva and the severity of oral mucositis during oropharyngeal radiation therapy.
    Epstein JB; Gorsky M; Guglietta A; Le N; Sonis ST
    Cancer; 2000 Dec; 89(11):2258-65. PubMed ID: 11147596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Z-100 as radiation mucositis protector in head and neck tumor management].
    Miyashita T; Morita S; Shibuya H; Takeda M; Horiuchi J
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Mar; 54(4):295-7. PubMed ID: 8177707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy.
    Trotti A; Garden A; Warde P; Symonds P; Langer C; Redman R; Pajak TF; Fleming TR; Henke M; Bourhis J; Rosenthal DI; Junor E; Cmelak A; Sheehan F; Pulliam J; Devitt-Risse P; Fuchs H; Chambers M; O'Sullivan B; Ang KK
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):674-81. PubMed ID: 14967419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oropharyngeal colonisation with fungi and gram-negative rods in patients treated with radiotherapy of the head and neck.
    Makkonen TA; Borthen L; Heimdahl A; Joensuu H; Lehtonen OP; Nord CE
    Br J Oral Maxillofac Surg; 1989 Aug; 27(4):334-40. PubMed ID: 2765463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of mucositis in irradiated head and neck cancer patients.
    Matthews RH; Ercal N
    J Exp Ther Oncol; 1996 Mar; 1(2):135-8. PubMed ID: 9414397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of benzydamine oral rinse in prevention and management of radiation-induced oral mucositis: A double-blind placebo-controlled randomized clinical trial.
    Sheibani KM; Mafi AR; Moghaddam S; Taslimi F; Amiran A; Ameri A
    Asia Pac J Clin Oncol; 2015 Mar; 11(1):22-7. PubMed ID: 25471468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Management of mucositis following radiotherapy for head and neck cancers].
    Lapeyre M; Charra-Brunaud C; Kaminsky MC; Geoffrois L; Dolivet G; Toussaint B; Maire F; Pourel N; Simon M; Marchal C; Bey P
    Cancer Radiother; 2001 Nov; 5 Suppl 1():121s-130s. PubMed ID: 11797271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
    Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
    Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Control of oral mucositis and candidiasis in marrow transplantation: a prospective, double-blind trial of chlorhexidine digluconate oral rinse.
    Ferretti GA; Ash RC; Brown AT; Parr MD; Romond EH; Lillich TT
    Bone Marrow Transplant; 1988 Sep; 3(5):483-93. PubMed ID: 3056555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms.
    Su CK; Mehta V; Ravikumar L; Shah R; Pinto H; Halpern J; Koong A; Goffinet D; Le QT
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):171-7. PubMed ID: 15337553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylaxis of oral mucositis in irradiated head-and-neck cancer patients: a proposed classification scheme of interventions and meta-analysis of randomized controlled trials.
    Sutherland SE; Browman GP
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):917-30. PubMed ID: 11240232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency of oral mucositis and microbiological analysis in children with acute lymphoblastic leukemia treated with 0.12% chlorhexidine gluconate.
    Soares AF; Aquino AR; Carvalho CH; Nonaka CF; Almeida D; Pinto LP
    Braz Dent J; 2011; 22(4):312-6. PubMed ID: 21861031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.